Skip to main content
. Author manuscript; available in PMC: 2013 Apr 14.
Published in final edited form as: Arch Intern Med. 2009 Mar 9;169(5):463–473. doi: 10.1001/archinternmed.2008.603

Table 5.

Microbiologic etiology by IE type in 2781 patients with definite endocarditis.

Native Valve IE
Intracardiac-Device IE
Drug Abusers (n=237) n (%) Non-Drug Abusers (n=1644) n (%) PVIE (n=563) n (%) Other devices (n=172)a n (%)
S. aureus 160 (68) 457 (28) 129 (23) 60 (35)
Coag Neg staph. 7 (3) 148 (9) 95 (17) 45 (26)
Viridans group strep 24 (10) 345 (21) 70 (12) 14 (8)
S. bovis 3 (1) 119 (7) 29 (5) 5 (3)
Other strep 5 (2) 118 (7) 26 (5) 7 (4)
Enterococci 11 (5) 179 (11) 70 (12) 10 (6)
HACEK 0 (0) 30 (2) 13 (2) 1 (1)
Fungi / Yeast 3 (1) 16 (1) 23 (4) 2 (1)
Polymicrobial 6 (3) 16 (1) 5 (1) 0 (0)
Culture negative 12 (5) 154 (9) 65 (12) 18 (11)
Other 6 (3) 62 (4) 38 (7) 10 (6)
Surgical therapy 89/234 (38)b 784/1639 (48) 274/561 (49) 104/172 (61)
In-hospital mortality 23/236 (10)b 281/1643 (17) 131/561 (23) 17/172 (10)

Abbreviations : IE = infective endocarditis; strep = streptococci; HACEK = Haemophilus spp., Aggregatibacter (formerly Actinobacillus) actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, and Kingella species; PVIE = prosthetic valve infective endocarditis.

a

Including pacemakers and implantable cardioverter defibrillators.

b

For pure right-sided IE only: 23/107 (22%) had surgical therapy and 6/108 (6%) died in hospital.